Newsletter Header Image
This Week's Edition of BeakerBeat 
November 21, 2011  
Mike Justice
Mike Justice
News Director
BeakerBeat

 

Pfizer concocts a plan to beat the generic competition for Lipitor, but will it work?  Plus, could it be true? 

 

A bi-partisan bill that would help medical device companies is introduced - we have the details of this shocking development. 

 

Which organization has analyzed the drug-shortage problem, calling it "highly concentrated," product-wise; the drugs represent just a small part of the overall pharma market.

 

The company conducting the world's first clinical trial of a therapy using human embryonic stem cells is halting that trial and leaving the stem cell business entirely.

 

Which company announced 100 new jobs with support from state and local incentives.

 

Our Muppet namesake is back on the silver screen this holiday season, but not before he appears at - a wrestling match? Watch Beaker wreak havoc in this.

 

All this and more on this week's edition of BeakerBeat. 

  Sponsored by Life Technologies          bb-11-21-11 

 

Have a comment on this episode?    Contact Mike at BeakerBeat

 

Win a Prize

Around the Watercooler

Key Stories from Around the Industry

 

Pfizer, J&J among lawmakers' fave drug stocks
Posted: 11/18/2011


What Geron's exit means for the stem cell field
Posted: 11/18/2011


Biotech veteran Martino becomes president and CEO of Ambit
Posted: 11/18/2011


St. Jude will move R&D facility to new location in Sunnyvale, Calif.
Posted: 11/18/2011


C.R. Bard, Endologix end patent dispute over stent graft
Posted: 11/18/2011


Par Pharmaceutical Completes Acquisition of Anchen
Posted: 11/17/2011


Medtronic to sell Physio-Control to Bain for $487 million
Posted: 11/17/2011


GOP senators grill FDA devices chief Shuren

Posted: 11/17/2011


Novartis workers end strike, but vow to fight on
Posted: 11/17/2011


Accuray to reduce workforce as part of cost-cutting measures
Posted: 11/17/2011


Europe kickstarts R&D fightback against superbugs
Posted: 11/17/2011


Johnson & Johnson Starts Removing Toxins from Baby Products
Posted: 11/16/2011


Three questions for Edwards Lifesciences CEO Michael Mussallem
Posted: 11/16/2011


Bayer chief aims for 37% pharma growth in China
Posted: 11/16/2011


Genentech's Levinson replaces Steve Jobs as Apple chairman
Posted: 11/15/2011


Ambit Biosciences Names Michael Martino President & CEO
Posted: 11/15/2011


The FTC Chair, Pay To Delay And Lobbying
Posted: 11/15/2011


Healthcare law will face Supreme Court before 2012 election
Posted: 11/15/2011


Has Amgen crossed into Big Pharma territory?
Posted: 11/14/2011


Obama, A Billionaire Donor & A No-Bid Contract
Posted: 11/14/2011


GSK fund aims to foster innovation in Canadian life sciences
Posted: 11/14/2011 

 

Beaker's Blog

   

Stryker plans restructuring in advance of device excise tax
Posted: 11/18/2011


Amgen officially part of Big Pharma, but at a cost
Posted: 11/18/2011


Poll: Most influential person in biopharmaceuticals industry?
Posted: 11/18/2011


Congress talks medical devices and the FDA
Posted: 11/17/2011


AHA Conference wraps up in Orlando for cardiovascular companies
Posted: 11/17/2011


Geron throws in the towel on stem cells
Posted: 11/16/2011


FDA Commish: Weve been underfunded for decades
Posted: 11/15/2011


Vaccines from plants? Medicago adds to NC life sciences
Posted: 11/14/2011


Life Technologies embraces social media with Life Even Better.
Posted: 11/14/2011 

Join Our Mailing List